Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys
Authors
Keywords
Virus testing, England, Antibodies, Serology, SARS CoV 2, COVID 19, Pandemics, Immunity
Journal
PLoS Computational Biology
Volume 17, Issue 9, Pages e1009436
Publisher
Public Library of Science (PLoS)
Online
2021-09-21
DOI
10.1371/journal.pcbi.1009436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
- (2021) Lewis F. Buss et al. SCIENCE
- Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
- (2021) Charlotte Manisty et al. EBioMedicine
- Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
- (2021) Ross J. Harris et al. JOURNAL OF INFECTION
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- OxCOVID19 Database, a multimodal data repository for better understanding the global impact of COVID-19
- (2021) Adam Mahdi et al. Scientific Reports
- Covid-19: Study claims real global deaths are twice official figures
- (2021) Owen Dyer BMJ-British Medical Journal
- Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
- (2021) Wan Ni Chia et al. Lancet Microbe
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)
- (2020) Thomas Nicol et al. JOURNAL OF CLINICAL VIROLOGY
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
- (2020) Silvia Stringhini et al. LANCET
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak
- (2020) C. Jessica E. Metcalf et al. TRENDS IN IMMUNOLOGY
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates
- (2020) Gideon Meyerowitz-Katz et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
- (2020) Anita S. Iyer et al. Science Immunology
- Persistence of IgG response to SARS-CoV-2
- (2020) Els Duysburgh et al. LANCET INFECTIOUS DISEASES
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
- (2012) Khayriyyah Mohd Hanafiah et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now